Stay updated on Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page.

Latest updates to the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page
- Check5 days agoChange DetectedA new page revision label Revision: v3.5.4 has been added, replacing the prior Revision: v3.5.3. This indicates the page has been updated to a newer version.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page footer’s revision/version label has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2; v3.5.2 was added and v3.5.0 was removed.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check98 days agoChange DetectedAdded new disease terms (primary peritoneal carcinoma and fallopian tube cancer) and new resources (Genetic and Rare Diseases Information Center; MedlinePlus Genetics). Updated the page revision from v3.4.1 to v3.4.2.SummaryDifference0.2%

Stay in the know with updates to Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page.